Gonadotropin-releasing hormone (GnRH) remedy improves cognitive perform in Down syndrome (DS) mouse fashions and male sufferers with DS, in response to a brand new research. The findings reveal a beforehand underappreciated position of GnRH – a hormone generally related to fertility and replica – in olfaction and cognition and supply a promising pathway towards therapies that would enhance the cognitive deficits in DS.
Down syndrome, also referred to as trisomy 21, is the most typical genetic reason behind mental incapacity and happens in a single in 30 pregnancies for girls aged 45 or extra and is attributable to having 3 copies of chromosome 21 as a substitute of the same old 2. Among the many varied medical manifestations related to the situation, many grownup DS sufferers expertise signs like these of early-onset Alzheimer’s illness, in addition to a gradual lack of olfaction.
Moreover, males with DS might also show deficits in sexual maturation. Presently, nonetheless, there are not any viable therapy choices for the cognitive and olfactory deficits related to DS. Current analysis has recommended that olfaction loss and male infertility can be a attribute of GnRH deficiency, and that GnRH could play a job in greater mind capabilities, comparable to cognition. Whether or not GnRH performs a job in DS pathology is not absolutely understood. In a mouse mannequin of DS, Maria Manfredi-Lozano and colleagues found that strands of microRNA regulating the manufacturing of GnRH – that are discovered on chromosome 21 – have been dysfunctional, leading to abnormalities within the neurons that secrete the hormone. Manfredi-Lozano et al. present that epigenetic, mobile, chemogenic, and pharmacological interventions that restore GnRH capabilities reversed olfactory and cognitive defects in DS mice in addition to in a mouse mannequin of Alzheimer’s illness.
Constructing on these findings, the authors performed a pilot medical trial to evaluate the consequences of GnRH remedy on cognition in seven grownup male DS sufferers. Whereas the therapy didn’t have an effect on olfaction, cognitive efficiency elevated in all however one of many contributors. In a associated perspective, Hanne Hoffmann discusses the research and its implications in larger element.
sources:
American Affiliation for the Development of Science (AAAS)
Journal reference:
Manfredi-Lozano, M., et al. (2022) GnRH alternative rescues cognition in Down Syndrome. Science. doi.org/10.1126/science.abq4515.
